Why is BCG solution used in intravesical BCG therapy?

BCG is a preparation related to a bacterium used in a controlled medical treatment. A clinician places the solution into the bladder through a catheter, where it stays for a planned period before being released. The goal is a local immune reaction rather than a medicine circulating throughout the body. Immune cells are encouraged to recognise and attack abnormal bladder cells. This approach is commonly used after surgery for certain non-muscle-invasive bladder cancers, when treatment needs to address cells that may remain in the bladder lining.

Because the bladder is the treatment site, urinary symptoms can occur for a short time after an installation. Burning, urgency, frequent urination, tiredness, or a mild fever can happen, but your oncology team should explain which effects are expected for you.

Follow the clinic’s instructions about fluids, medicines, and how long to hold the solution. Tell the team before treatment if you have a fever, a urinary infection, difficulty passing urine, or recent bladder injury. Afterward, follow their hygiene and toilet guidance, wash your hands carefully, and drink according to the advice you were given. Keep a record of urinary symptoms and temperature so changes are easier to discuss.

Contact your oncology team promptly for a high or persistent fever, chills, feeling faint, worsening illness, severe bladder pain, inability to pass urine, or heavy blood in the urine. These symptoms need assessment because a stronger infection or another treatment problem may need attention.

Ask why BCG is recommended for your bladder cancer, how an installation will be performed, how long you should hold it, which symptoms are expected, and who to call outside clinic hours. You can also ask when treatment may be delayed and how response will be checked.